![Review: Precision Medicine Approaches for Genetic Cardiomyopathy: Targeting Phospholamban R14del | SpringerLink Review: Precision Medicine Approaches for Genetic Cardiomyopathy: Targeting Phospholamban R14del | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11897-022-00558-x/MediaObjects/11897_2022_558_Fig1_HTML.png)
Review: Precision Medicine Approaches for Genetic Cardiomyopathy: Targeting Phospholamban R14del | SpringerLink
![Prince William Times 01/27/2022 by Fauquier Times (52 issues) & Prince William Times (52 issues) - Issuu Prince William Times 01/27/2022 by Fauquier Times (52 issues) & Prince William Times (52 issues) - Issuu](https://image.isu.pub/220127120854-ba1a8a64a4013847b8caeafd3f5db09a/jpg/page_1.jpg)
Prince William Times 01/27/2022 by Fauquier Times (52 issues) & Prince William Times (52 issues) - Issuu
![Review: Precision Medicine Approaches for Genetic Cardiomyopathy: Targeting Phospholamban R14del | SpringerLink Review: Precision Medicine Approaches for Genetic Cardiomyopathy: Targeting Phospholamban R14del | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11897-022-00558-x/MediaObjects/11897_2022_558_Fig3_HTML.png)
Review: Precision Medicine Approaches for Genetic Cardiomyopathy: Targeting Phospholamban R14del | SpringerLink
![mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells - ScienceDirect mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213231722000404-gr1.jpg)